InMed Pharmaceuticals Files 8-K with Corporate Updates
Ticker: INM · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1728328
Sentiment: neutral
Topics: corporate-filing, regulation-fd, financials
TL;DR
InMed Pharma filed an 8-K on 6/24/25 - check for Reg FD and financial updates.
AI Summary
InMed Pharmaceuticals Inc. filed an 8-K on June 24, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 1445-885 West Georgia St., Vancouver, B.C., Canada, V6C 3E8, with a principal business phone number of (604) 669-7207. The company is incorporated in British Columbia and operates within the Pharmaceutical Preparations industry.
Why It Matters
This filing provides essential corporate information and disclosures for InMed Pharmaceuticals Inc., which is relevant for investors and stakeholders tracking the company's regulatory compliance and operational details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Numbers
- 001-39685 — Commission File Number (Identifies the company's filing with the SEC.)
- 2834 — SIC Code (Indicates the company operates in Pharmaceutical Preparations.)
Key Players & Entities
- InMed Pharmaceuticals Inc. (company) — Filer
- June 24, 2025 (date) — Date of earliest event reported
- Vancouver, B.C. Canada (location) — Principal Executive Offices
- 001-39685 (other) — Commission File Number
- 2834 (other) — Standard Industrial Classification Code
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in this header information.
What are the key financial statements or exhibits being filed?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these documents is not detailed in the provided text.
What is InMed Pharmaceuticals Inc.'s primary business activity?
InMed Pharmaceuticals Inc. is classified under Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
Where are InMed Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at Suite 1445 - 885 W. Georgia Street, Vancouver, B.C. Canada, V6C 3E8.
What is the company's telephone number?
The company's telephone number, including area code, is (604) 669-7207.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding InMed Pharmaceuticals Inc. (INM).